Skip to content
LexBuild

Early Alzheimer's Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability

---
identifier: "/us/fr/C1-2024-05178"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Early Alzheimer's Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability"
title_number: 0
title_name: "Federal Register"
section_number: "C1-2024-05178"
section_name: "Early Alzheimer's Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability"
positive_law: false
currency: "2024-03-18"
last_updated: "2024-03-18"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "C1-2024-05178"
document_type: "notice"
publication_date: "2024-03-18"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "89 FR 19329"
fr_volume: 89
docket_ids:
  - "Docket No. FDA-2013-D-0077"
---

#  Early Alzheimer's Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability

**Correction**

In notice document 2024-05178, appearing on pages 17850 through 17851 in the issue of Tuesday, March 12, 2024, make the following correction:

On page 17850, in the second column, on the third line, “May 13, 2024” should read “June 10, 2024”.